Hengeveld PJ, van der Klift MY, Kolijn PM, Davi F, et al. Detecting measurable residual disease beyond 10-4 by an IGHV leader-based NGS approach improves prognostic stratification in CLL. Blood 2023;141:519-528.
PMID: 36084320